Andrea Choe is co-founder and CEO of Holoclara, the first company to create safe, orally available worm-derived therapies. While pursuing her doctorate at the California Institute of Technology, she uncovered a unique pheromone language shared by roundworms that may have evolved over hundreds of millions of years. Choe’s research, including her discovery of novel molecules derived from worms that blocked formation of disease in animal models of allergic and autoimmune disease, has led to advances in the fields of evolutionary biology and extreme biology. Her work has become the foundation of Holoclara’s technology and mission to pioneer a new class of therapeutics that can provide relief for millions of people living with chronic and debilitating diseases. Choe is a winner of the Emerging Women Founders in Biotech Award.
Previously
In less-developed countries, parasitic roundworms can colonize the gut and cause significant intestinal problems. But autoimmune diseases, the devastating package of disorders...
Join us to kickoff Aspen Ideas: Health 2024 with welcome remarks from Aspen Institute leaders, 10 Big Ideas from Aspen Ideas: Health speakers, and a special performance from t...